These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18160297)

  • 1. Oligo(tyrosine sulfate)s as heparin pentasaccharide mimic: evaluation by surface noncovalent affinity mass spectrometry.
    Yamaguchi M; Ohmori T; Sakata Y; Ueki M
    Bioorg Med Chem; 2008 Mar; 16(6):3342-51. PubMed ID: 18160297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence and circular dichroism studies during the interactions of sulfated polysaccharides with antithrombin III.
    Tanyi A; Benjamin V; Sadberry AJ; Doctor VM
    Thromb Res; 1995 Mar; 77(6):505-13. PubMed ID: 7542805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity interaction between a synthetic, highly negatively charged pentasaccharide and alpha- or beta-antithrombin is predominantly due to nonionic interactions.
    Hjelm R; Schedin-Weiss S
    Biochemistry; 2007 Mar; 46(11):3378-84. PubMed ID: 17323934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic modification of heparan sulfate on a biochip promotes its interaction with antithrombin III.
    Hernaiz M; Liu J; Rosenberg RD; Linhardt RJ
    Biochem Biophys Res Commun; 2000 Sep; 276(1):292-7. PubMed ID: 11006120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?
    Petitou M; van Boeckel CA
    Angew Chem Int Ed Engl; 2004 Jun; 43(24):3118-33. PubMed ID: 15199558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of new synthetic heparin mimetics.
    Hérault JP; Bernat A; Roye F; Michaux C; Schaeffer P; Bono F; Petitou M; Herbert JM
    Thromb Haemost; 2002 Jun; 87(6):985-9. PubMed ID: 12083506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of heparin binding to antithrombin III by crossed immunoelectrophoresis.
    Barrowcliffe TW
    Thromb Haemost; 1980 Feb; 42(5):1434-45. PubMed ID: 7368150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A heparin-binding synthetic peptide of heparin/heparan sulfate-interacting protein modulates blood coagulation activities.
    Liu S; Zhou F; Höök M; Carson DD
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1739-44. PubMed ID: 9050848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin binding domain peptides of antithrombin III: analysis by isothermal titration calorimetry and circular dichroism spectroscopy.
    Tyler-Cross R; Sobel M; Marques D; Harris RB
    Protein Sci; 1994 Apr; 3(4):620-7. PubMed ID: 8003980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on interactions of oligo(tyrosine sulfate)s with synthetic heparin-binding peptides by affinity chromatography and MALDI-TOF-MS.
    Yamaguchi M; Ueki M
    Adv Exp Med Biol; 2009; 611():529-30. PubMed ID: 19400298
    [No Abstract]   [Full Text] [Related]  

  • 11. The structure of glycosaminoglycans and their interactions with proteins.
    Gandhi NS; Mancera RL
    Chem Biol Drug Des; 2008 Dec; 72(6):455-82. PubMed ID: 19090915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity.
    Choay J; Petitou M; Lormeau JC; Sinaÿ P; Casu B; Gatti G
    Biochem Biophys Res Commun; 1983 Oct; 116(2):492-9. PubMed ID: 6651824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosaminoglycans as naturally occurring combinatorial libraries: developing a mass spectrometry-based strategy for characterization of anti-thrombin interaction with low molecular weight heparin and heparin oligomers.
    Abzalimov RR; Dubin PL; Kaltashov IA
    Anal Chem; 2007 Aug; 79(16):6055-63. PubMed ID: 17658885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A heparin binding synthetic peptide from human HIP / RPL29 fails to specifically differentiate between anticoagulantly active and inactive species of heparin.
    Hoke DE; Carson DD; Höök M
    J Negat Results Biomed; 2003 Feb; 2():1. PubMed ID: 12659638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis.
    Fermas S; Gonnet F; Sutton A; Charnaux N; Mulloy B; Du Y; Baleux F; Daniel R
    Glycobiology; 2008 Dec; 18(12):1054-64. PubMed ID: 18796646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymatic synthesis of antithrombin III-binding heparan sulfate pentasaccharide.
    Kuberan B; Lech MZ; Beeler DL; Wu ZL; Rosenberg RD
    Nat Biotechnol; 2003 Nov; 21(11):1343-6. PubMed ID: 14528313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human antithrombin III-derived heparin-binding peptide, a novel heparin antagonist.
    Onoue S; Nemoto Y; Harada S; Yajima T; Kashimoto K
    Life Sci; 2003 Oct; 73(22):2793-806. PubMed ID: 14511765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dansyl (5-dimethylaminonaphthalene-1-sulphonyl)-heparin binds antithrombin III and platelet factor 4 at separate sites.
    Piepkorn MW
    Biochem J; 1981 May; 196(2):649-51. PubMed ID: 7317004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of heparin oligosaccharides binding specifically to antithrombin III using mass spectrometry.
    Naimy H; Leymarie N; Bowman MJ; Zaia J
    Biochemistry; 2008 Mar; 47(10):3155-61. PubMed ID: 18260648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three novel high performance affinity chromatographic media for the separation of antithrombin III from human plasma.
    Zhao Y; Zhao R; Shangguan D; Xiong S; Liu G
    Biomed Chromatogr; 2001 Dec; 15(8):487-92. PubMed ID: 11748680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.